These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 27650288)
1. Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade? Fielding S; Ogbuagu A; Sivasubramaniam S; MacLennan G; Ramsay CR Qual Life Res; 2016 Dec; 25(12):2977-2983. PubMed ID: 27650288 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data. Tan PT; Cro S; Van Vogt E; Szigeti M; Cornelius VR BMC Med Res Methodol; 2021 Apr; 21(1):72. PubMed ID: 33858355 [TBL] [Abstract][Full Text] [Related]
4. Handling missing data in RCTs; a review of the top medical journals. Bell ML; Fiero M; Horton NJ; Hsu CH BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057 [TBL] [Abstract][Full Text] [Related]
5. A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes. Fielding S; Maclennan G; Cook JA; Ramsay CR Trials; 2008 Aug; 9():51. PubMed ID: 18694492 [TBL] [Abstract][Full Text] [Related]
6. Informative censoring due to missing data in quality of life was inadequately assessed in most oncology randomized controlled trials. Olivier T; Haslam A; Prasad V J Clin Epidemiol; 2021 Nov; 139():80-86. PubMed ID: 34311054 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes. Ibrahim F; Tom BD; Scott DL; Prevost AT Trials; 2016 Jun; 17(1):272. PubMed ID: 27255212 [TBL] [Abstract][Full Text] [Related]
8. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285 [TBL] [Abstract][Full Text] [Related]
9. Are missing data adequately handled in cluster randomised trials? A systematic review and guidelines. Díaz-Ordaz K; Kenward MG; Cohen A; Coleman CL; Eldridge S Clin Trials; 2014 Oct; 11(5):590-600. PubMed ID: 24902924 [TBL] [Abstract][Full Text] [Related]
10. The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature. Rombach I; Rivero-Arias O; Gray AM; Jenkinson C; Burke Ó Qual Life Res; 2016 Jul; 25(7):1613-23. PubMed ID: 26821918 [TBL] [Abstract][Full Text] [Related]
11. Current practice in analysing and reporting binary outcome data-a review of randomised controlled trial reports. Rombach I; Knight R; Peckham N; Stokes JR; Cook JA BMC Med; 2020 Jun; 18(1):147. PubMed ID: 32507111 [TBL] [Abstract][Full Text] [Related]
12. What is meant by intention to treat analysis? Survey of published randomised controlled trials. Hollis S; Campbell F BMJ; 1999 Sep; 319(7211):670-4. PubMed ID: 10480822 [TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
14. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Wood AM; White IR; Thompson SG Clin Trials; 2004; 1(4):368-76. PubMed ID: 16279275 [TBL] [Abstract][Full Text] [Related]
15. Predicting missing quality of life data that were later recovered: an empirical comparison of approaches. Fielding S; Fayers P; Ramsay C Clin Trials; 2010 Aug; 7(4):333-42. PubMed ID: 20576672 [TBL] [Abstract][Full Text] [Related]
16. The rise of multiple imputation: a review of the reporting and implementation of the method in medical research. Hayati Rezvan P; Lee KJ; Simpson JA BMC Med Res Methodol; 2015 Apr; 15():30. PubMed ID: 25880850 [TBL] [Abstract][Full Text] [Related]
17. Analysis and reporting of adverse events in randomised controlled trials: a review. Phillips R; Hazell L; Sauzet O; Cornelius V BMJ Open; 2019 Mar; 9(2):e024537. PubMed ID: 30826796 [TBL] [Abstract][Full Text] [Related]
19. Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately. Khan NA; Torralba KD; Aslam F RMD Open; 2021 Jul; 7(2):. PubMed ID: 34330848 [TBL] [Abstract][Full Text] [Related]
20. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]